---

---

Acetaminophen  

save search

---

Paracetamol IV Global Market Report 2023: Enhanced Usage of Acetaminophen to Reduce the Dependence on Opioids for Pain Management Drives Growth
Published: 2023-04-26 (Crawled : 19:00) - prnewswire.com
MNK | $0.3402 -0.06% 540K |

n/a

| -92.84% | O: -1.93% H: 0.0% C: -4.84%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 7.63% | O: -2.1% H: 0.0% C: 0.0%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -7.98% | O: -0.39% H: 0.58% C: 0.5%
JNJ | News | $149.12 0.82% 0.0% 9.3M |

Health Technology

| -9.05% | O: 0.17% H: 0.31% C: 0.06%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -19.88% | O: -3.56% H: 0.0% C: 0.0%
management report global growth market

---

Update on Supply of Children's Acetaminophen and Ibuprofen Products
Published: 2022-10-07 (Crawled : 13:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M |

Health Technology

| -10.18% | O: -1.63% H: 0.0% C: 0.0%
update

---

Adial Pharmaceuticals Announces Positive In Vivo Data for Purnovate’s PNV-5030 as a Potential Treatment for Chronic PainPNV-5030 significantly reduced pain compared to both placebo and acetaminophen
Published: 2022-09-26 (Crawled : 14:00) - biospace.com/
ADIL | News | $1.895 -1.81% -1.85% 2.5M |

Health Technology

| 413.57% | O: -0.35% H: 6.28% C: 3.18%
pnv-5030 treatment pharmaceuticals potential positive

---

Gainers vs Losers

75%

25%

Top 10 Gainers

MTTR | News M | $4.78 174.71% 63.6% 72M |

AGBA | $2.565 105.2% 51.27% 200M |

Finance

MLEC | $2.44 74.29% 42.62% 78M |

n/a

EDBL | News | $6.28 67.02% 40.13% 16M |

ATGL | $2.91 48.81% 32.8% 180K |

ZAPP | $0.2175 47.16% 32.05% 16M |

n/a

ONFO | $0.6075 38.38% 27.74% 7.3M |

n/a

VIVK | $1.48 38.32% 27.7% 530K |

Professional, Scientific, and T...

MNTS | $0.5 35.69% 26.3% 4.8M |

SDIG A | $3.635 35.13% 26.0% 1M |

---

Your saved searches

---